-
DE
A specialist in nuclear medicine uses radioactive substances for the diagnosis and treatment of diseases. Key procedures include PET, SPECT, scintigraphy, and radionuclide therapies.
A specialist in nuclear medicine uses radioactive substances for the diagnosis and treatment of diseases. Key procedures include PET, SPECT, scintigraphy, and radionuclide therapies.
A specialist in nuclear medicine is a physician trained in the diagnostic and therapeutic use of radioactive substances, known as radionuclides. The field integrates knowledge from physics, chemistry, biology, and medicine, and plays an essential role in modern high-performance healthcare.
Following medical school, aspiring nuclear medicine specialists complete a multi-year residency program in which they learn the specific techniques, equipment, and radiation protection measures associated with the field. In Germany, the specialist training program in nuclear medicine typically takes five years.
A nuclear medicine specialist works in both diagnostics and therapy. The main areas of practice include:
In scintigraphy, a weakly radioactive substance called a radiotracer is administered to the patient. It accumulates in a specific organ or tissue, and a gamma camera detects the emitted radiation to produce a functional image of that organ. Common applications include thyroid, bone, kidney, and cardiac scintigraphy.
Positron emission tomography (PET) is a highly sensitive imaging method that visualizes metabolic processes in the body. When combined with computed tomography (PET-CT), it delivers both functional and anatomical information. PET-CT is particularly valuable in oncology (cancer diagnostics), neurology, and cardiology.
SPECT is an advanced form of conventional scintigraphy that produces three-dimensional cross-sectional images. It is frequently used in the diagnosis of cardiac, neurological, and skeletal conditions.
Radioiodine therapy is a well-established treatment for thyroid diseases, particularly hyperthyroidism, benign thyroid enlargement (goiter), and differentiated thyroid carcinoma. Radioactive iodine (iodine-131) is swallowed, selectively accumulates in thyroid tissue, and destroys it through targeted radiation.
PSMA therapy (Lutetium-177-PSMA) is an innovative treatment for patients with advanced prostate cancer. A radioactively labeled molecule binds specifically to prostate-specific membrane antigen (PSMA) on cancer cells and irradiates them from within.
Further applications of radionuclide therapy include treatment of neuroendocrine tumors via PRRT (peptide receptor radionuclide therapy), management of bone metastases, and various palliative treatment approaches.
Patients are generally referred to a nuclear medicine specialist by another physician. Common reasons for referral include:
The path to becoming a nuclear medicine specialist begins with a completed medical degree and full medical licensure. This is followed by a residency of at least five years at an accredited training facility. Key components of the training program include:
The specialist examination is taken before the relevant medical board (Aerztekammer).
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.